...
首页> 外文期刊>Interactive cardiovascular and thoracic surgery >Irrigated radiofrequency ablation is a safe and effective technique to treat chronic atrial fibrillation
【24h】

Irrigated radiofrequency ablation is a safe and effective technique to treat chronic atrial fibrillation

机译:射频消融是治疗慢性心房颤动的一种安全有效的技术

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The safety of intraoperative non-irrigated temperature-controlled radiofrequency ablation to treat atrial fibrillation is a matter of debate. This study evaluates a different operative technique using saline-irrigated-cooled-tip radiofrequency ablation (SICTRA) to treat atrial fibrillation. One hundred and twenty-four concomitant anti-arrhythmic procedures, using SICTRA were performed; 113 to treat chronic AF (>6 months) and 11 to cure paroxysmal AF. Twenty-eight MVP, 42 MVR, 17 AVR and six double valve procedures with or without CABG, one ASD closure and 30 solitary CABG were performed. The mean (S.D.) left atrial diameter, preoperative duration of AF, aortic cross-clamp time were 50.5 mm (9.8), 57 months (64) and 99 min (21). Thirty day mortality was 4.8% (6/124; euroscore 17, 11, 8, 8, 6, 5). Autopsies did not reveal any esophageal, pulmonary orifice, or circumflex artery injuries. No ablation related bleeding was observed. Mean follow-up (S.D.) was 19.7 months (14.4). Fourteen patients died during follow-up. The cumulative postoperative SR at 6 and 12 months was 60% and 70%. The cumulative survival at 1 and 2 years was 86% and 83%. Irrigated radiofrequency ablation was effective. It was not associated with procedural complications in our series.
机译:术中非灌溉温控射频消融治疗房颤的安全性尚有争议。这项研究评估了一种不同的手术技术,使用盐水冲洗冷却尖端射频消融术(SICTRA)来治疗房颤。使用SICTRA进行了124次伴随的抗心律不齐手术; 113例可治疗慢性AF(> 6个月),11例可治疗阵发性AF。进行了28次MVP,42次MVR,17次AVR和6次双瓣膜手术(有或没有CABG,一个ASD闭合和30个单独的CABG)。左心房平均直径(S.D.),术前房颤持续时间,主动脉夹钳时间分别为50.5毫米(9.8),57个月(64)和99分钟(21)。 30天死亡率为4.8%(6/124;欧洲分数17、11、8、8、6、5)。尸检未发现任何食道,肺孔或回旋动脉损伤。没有观察到与消融有关的出血。平均随访(S.D.)为19.7个月(14.4)。随访期间有14名患者死亡。术后6个月和12个月的累积SR分别为60%和70%。 1年和2年的累积生存率分别为86%和83%。射频射频消融治疗有效。它与我们系列中的程序并发症无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号